Research field (3):
Tumor biology
, Experimental pathology
, Pathobiochemistry
Research keywords (10):
bone and soft tissue sarcoma
, fusion gene
, 発生母地
, mouse model
, carcinogenesis
, エピゲノム
, スーパーエンハンサー
, 血管新生
, がん転移
, translocation
Research theme for competitive and other funds (1):
2024 - 2028 Application of epigenome editing to advance the targeted therapy for sarcoma
Papers (37):
Surachada Chuaychob, Ruyin Lyu, Miwa Tanaka, Ayumi Haginiwa, Atsuya Kitada, Takuro Nakamura, Ryuji Yokokawa. Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip. Proceedings of the National Academy of Sciences of the United States of America. 2024. 121. 13. e2312472121
Keiichi Ishihara, Ryuto Sakoda, Masako Mizoguchi, Mitsugu Fujita, Chiami Moyama, Yuri Okutani, Kazuyuki Takata, Miwa Tanaka, Takashi Minami, Haruhiko Sago, et al. Suppression of Sleeping Beauty-induced Gliomagenicity in Ts1Cje Mice, a Model of Down Syndrome. Anticancer research. 2024. 44. 2. 489-495
Takuro Nakamura, Miwa Tanaka. [Alveolar Soft Part Sarcoma-The Angiogenic Mechanism Regulated by a Fusion Gene Product]. Gan to kagaku ryoho. Cancer & chemotherapy. 2024. 51. 6. 585-590
田中美和, 田中美和, 角南義孝, 中村卓郎, 丸山玲緒. Application of epigenome editing technology for targeted cancer therapy. 日本ゲノム編集学会大会要旨集. 2024. 9th
日本がん転移学会
, Japanese Association of Sarcoma Treatment and Researc
, The Molecular Biology Society of Japan
, The Japanese Society of Pathology
, The Japanese Cancer Association